The pathogenesis and treatment of no-reflow occurring during percutaneous coronary intervention

Cardiovascular Revascularization Medicine

Volumn 9, Issue 1, 2008, Pages 56-61

  Movahed, Mohammad Reza ^a   Butman, Samuel M ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Balloon angioplasty; Complications; No reflow; PCI; Percutaneous coronary intervention; PTCA; Stenting

Indexed keywords

ADENOSINE; ADRENALIN; DILTIAZEM; FIBRINOGEN RECEPTOR ANTAGONIST; NICARDIPINE; NICORANDIL; NITROPRUSSIDE SODIUM; VERAPAMIL;

AGED; ANGIOPLASTY; BRADYCARDIA; CASE REPORT; COLLAPSE; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; DEATH; DRUG MEGADOSE; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; HYPOTENSION; INCIDENCE; MALE; PATHOGENESIS; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SAPHENOUS VEIN GRAFT; THORAX PAIN; UNSTABLE ANGINA PECTORIS; VASODILATATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; DRUG-ELUTING STENTS; HUMANS; MALE; NO-REFLOW PHENOMENON; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 38149113860     PISSN: 15538389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carrev.2007.08.005     Document Type: Review

References (46)

1. Kloner R., Ganote C., and Jennings R. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54 (1974) 1496-1508
2. Kelly R., Cohen M., and Stouffer G. Incidence and management of "no-reflow" following percutaneous coronary interventions. Am J Med Sci 329 (2005) 78-85
3. Piana R., Paik G., Moscucci M., Cohen D., Gibson C., Kugelmass A., Carrozza J., Kuntz R., and Baim D. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation 89 (1994) 2514-2518
4. Vallejo E., Pena-Duque M., Norono O., Ban Hayashi E., Gaspar J., Villavicencio R., and Rios Martinez M. The no-reflow phenomenon: its incidence and clinical characteristics in a series of cases. Arch Inst Cardiol Mex 68 (1998) 247-252
5. Eeckhout E., and Kern M. The coronary no-reflow phenomenon: a review of mechanisms and therapies. Eur Heart J 22 (2001) 729-739
6. Costantini C., Stone G., Mehran R., Aymong E., Grines C., Cox D., Stuckey T., Turco M., Gersh B., Tcheng J., Garcia E., Griffin J., Guagliumi G., Leon M., and Lansky A. Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction. J Am Coll Cardiol 44 (2004) 305-312
7. Iwakura K., Ito H., Ikushima M., Kawano S., Okamura A., Asano K., Kuroda T., Tanaka K., Masuyama T., Hori M., and Fujii K. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 41 (2003) 1-7
8. Taniyama Y., Ito H., Iwakura K., Masuyama T., Hori M., Takiuchi S., Nishikawa N., Higashino Y., Fujii K., and Minamino T. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol 30 (1997) 1193-1199
9. Engler R., Schmid-Schonbein G., and Pavelec R. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 111 (1983) 98-111
10. Jennings R., Ganote C., Kloner R., Whalen Jr. D., and Hamilton D. Explosive swelling of myocardial cells irreversibly injured by transient ischemia. Recent Adv Stud Cardiac Struct Metab 6 (1975) 405-413
11. Klein L., Kern M., Berger P., Sanborn T., Block P., Babb J., Tommaso C., Hodgson J., and Feldman T. Society of cardiac angiography and interventions: suggested management of the no-reflow phenomenon in the cardiac catheterization laboratory. Catheter Cardiovasc Interv 60 (2003) 194-201
12. Abbo K., Dooris M., Glazier S., O'Neill W., Byrd D., Grines C., and Safian R. Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol 75 (1995) 778-782
13. Kotani J., Nanto S., Mintz G., Kitakaze M., Ohara T., Morozumi T., Nagata S., and Hori M. Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation 106 (2002) 1672-1677
14. Tanaka A., Kawarabayashi T., Nishibori Y., Sano T., Nishida Y., Fukuda D., Shimada K., and Yoshikawa J. No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation 105 (2002) 2148-2152
15. Fugit M., Rubal B., and Donovan D. Effects of intracoronary nicardipine, diltiazem and verapamil on coronary blood flow. J Invasive Cardiol 12 (2000) 80-85
16. Resnic F., Wainstein M., Lee M., Behrendt D., Wainstein R., Ohno-Machado L., Kirshenbaum J., Rogers C., Popma J., and Piana R. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am Heart J 145 (2003) 42-46
17. Movahed M., Balian H., and Moraghebi P. Reversible severe ischemic mitral regurgitation and cardiogenic shock as a complication of percutaneous coronary intervention. J Invasive Cardiol 17 (2005) 104-107
18. Lee C., Wong H., Tan H., Zhang J., Teo S., Ong H., Low A., Sutandar A., and Lim Y. Impact of reversibility of no reflow phenomenon on 30-day mortality following percutaneous revascularization for acute myocardial infarction-insights from a 1,328 patient registry. J Interv Cardiol 18 (2005) 261-266
19. Morishima I., Sone T., Okumura K., Tsuboi H., Kondo J., Mukawa H., Matsui H., Toki Y., Ito T., and Hayakawa T. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 36 (2000) 1202-1209
20. Sangiorgi G., and Colombo A. Embolic protection devices. Heart 89 (2003) 990-992
21. Stone G., Rogers C., Hermiller J., Feldman R., Hall P., Haber R., Masud A., Cambier P., Caputo R., Turco M., Kovach R., Brodie B., Herrmann H., Kuntz R., Popma J., Ramee S., and Cox D. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation 108 (2003) 548-553
22. Huang Z., Katoh O., Nakamura S., Negoro S., Kobayashi T., and Tanigawa J. Evaluation of the PercuSurge Guardwire Plus Temporary Occlusion and Aspiration System during primary angioplasty in acute myocardial infarction. Catheter Cardiovasc Interv 60 (2003) 443-451
23. Stone G., Webb J., Cox D., Brodie B., Qureshi M., Kalynych A., Turco M., Schultheiss H., Dulas D., Rutherford B., Antoniucci D., Krucoff M., Gibbons R., Jones D., Lansky A., and Mehran R. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 293 (2005) 1063-1072
24. Amado L., Kraitchman D., Gerber B., Castillo E., Boston R., Grayzel J., and Lima J. Reduction of "no-reflow" phenomenon by intra-aortic balloon counterpulsation in a randomized magnetic resonance imaging experimental study. J Am Coll Cardiol 43 (2004) 1291-1298
25. Gick M., Jander N., Bestehorn H., Kienzle R., Ferenc M., Werner K., Comberg T., Peitz K., Zohlnhofer D., Bassignana V., Buettner H., and Neumann F. Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation 112 (2005) 1462-1469
26. Ali A., Cox D., Dib N., Brodie B., Berman D., Gupta N., Browne K., Iwaoka R., Azrin M., Stapleton D., Setum C., and Popma J. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. J Am Coll Cardiol 48 (2006) 244-252
27. de Lemos J., Antman E., Gibson C., McCabe C., Giugliano R., Murphy S., Coulter S., Anderson K., Scherer J., Frey M., Van Der Wieken R., Van De Werf F., and Braunwald E. Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial. Circulation 101 (2000) 239-243
28. Giri S., Mitchel J., Hirst J., McKay R., Azar R., Mennett R., Waters D., and Kiernan F. Synergy between intracoronary stenting and abciximab in improving angiographic and clinical outcomes of primary angioplasty in acute myocardial infarction. Am J Cardiol 86 (2000) 269-274
29. Roffi M., Mukherjee D., Chew D., Bhatt D., Cho L., Robbins M., Ziada K., Brennan D., Ellis S., and Topol E. Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials. Circulation 106 (2002) 3063-3067
30. Bellandi F., Maioli M., Gallopin M., Toso A., and Dabizzi R. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention. Catheter Cardiovasc Interv 62 (2004) 186-192
31. Wohrle J., Grebe O., Nusser T., Al-Khayer E., Schaible S., Kochs M., Hombach V., and Hoher M. Reduction of major adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty. Circulation 107 (2003) 1840-1843
32. Claeys M., Bosmans J., De Ceuninck M., Beunis A., Vergauwen W., Vorlat A., and Vrints C. Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction. Am J Cardiol 94 (2004) 9-13
33. Ishibashi F., Saito T., Hokimoto S., Noda K., Moriyama Y., and Oshima S. Combined revascularization strategy for acute myocardial infarction in patients with intracoronary thrombus: preceding intracoronary thrombolysis and subsequent mechanical angioplasty. Jpn Circ J 65 (2001) 251-256
34. Hanna G., Yhip P., Fujise K., Schroth G., Rosales O., Anderson H., and Smalling R. Intracoronary adenosine administered during rotational atherectomy of complex lesions in native coronary arteries reduces the incidence of no-reflow phenomenon. Catheter Cardiovasc Interv 48 (1999) 275-278
35. Kaplan B., Benzuly K., Kinn J., Bowers T., Tilli F., Grines C., O'Neill W., and Safian R. Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin. Cathet Cardiovasc Diagn 39 (1996) 113-118
36. Michaels A., Appleby M., Otten M., Dauterman K., Ports T., Chou T., and Gibson C. Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial. J Invasive Cardiol 14 (2002) 299-302
37. Dillon W., Hadian D., and Ritchie M. Refractory no-reflow successfully treated with local infusion of high-dose adenosine and verapamil-a case report. Angiology 52 (2001) 137-141
38. Demir I., Yilmaz H., Ermis C., and Sancaktar O. Treatment of no-reflow phenomenon with verapamil after primary stent deployment during myocardial infarction. Jpn Heart J 43 (2002) 573-580
39. Fischell T., Carter A., Foster M., Hempsall K., De Vries J., Kim D., and Kloostra A. Reversal of "no reflow" during vein graft stenting using high velocity boluses of intracoronary adenosine. Cathet Cardiovasc Diagn 45 (1998) 360-365
40. Marzilli M., Orsini E., Marraccini P., and Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 101 (2000) 2154-2159
41. Pasceri V., Pristipino C., Pelliccia F., Granatelli A., Speciale G., Roncella A., Pironi B., Capasso M., and Richichi G. Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction. Am J Cardiol 95 (2005) 1358-1361
42. Skelding K., Goldstein J., Mehta L., Pica M., and O'Neill W. Resolution of refractory no-reflow with intracoronary epinephrine. Catheter Cardiovasc Interv 57 (2002) 305-309
43. Saito T., Hokimoto S., Ishibashi F., Noda K., and Oshima S. Pulse infusion thrombolysis (PIT) for large intracoronary thrombus: preventive effect against the 'no flow' phenomenon in revascularization therapy for acute myocardial infarction. Jpn Circ J 65 (2001) 94-98
44. Herrmann H., Moliterno D., Ohman E., Stebbins A., Bode C., Betriu A., Forycki F., Miklin J., Bachinsky W., Lincoff A., Califf R., and Topol E. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) Trial. J Am Coll Cardiol 36 (2000) 1489-1496
45. Barcin C., Denktas A., Lennon R., Hammes L., Higano S., Holmes Jr. D., Garratt K., and Lerman A. Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon. Catheter Cardiovasc Interv 61 (2004) 484-491
46. Lim S., Bae E., Jeong M., Kang D., Lee Y., Kim K., Lee S., Yoon K., Hong S., Park H., Hong Y., Kim J., Kim W., Ahn Y., Cho J., Park J., and Kang J. Effect of combined intracoronary adenosine and nicorandil on no-reflow phenomenon during percutaneous coronary intervention. Circ J 68 (2004) 928-932